Symbicort Turbuhaler

Symbicort Turbuhaler Indications/Uses

budesonide + formoterol

Manufacturer:

AstraZeneca

Distributor:

Zuellig Pharma
Full Prescribing Info
Indications/Uses
Asthma: Symbicort Turbuhaler is indicated for the treatment of asthma, to achieve overall asthma control, including the relief of symptoms and the reduction of the risk of exacerbations (see Dosage & Administration).
Note: Symbicort (80/4.5 micrograms/inhalation) is not appropriate in patients with severe asthma.
Chronic Obstructive Pulmonary Disease (COPD): Symbicort Turbuhaler is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with COPD with FEV1 < 70% predicted normal (post bronchodilator) and an exacerbation history despite regular bronchodilator therapy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in